Smoking cessation treatment targets adolescents

This study found that while there was no significant difference between the varenicline group and the placebo group at end of treatment, those in the varenicline group quit earlier in the trial and were less likely to relapse after the trial was over. And it encourages new treatments designs for adolescents.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news